EP4719346A1 - Nouvelles combinaisons de principes actifs, compositions les contenant et leur utilisation en thérapie - Google Patents

Nouvelles combinaisons de principes actifs, compositions les contenant et leur utilisation en thérapie

Info

Publication number
EP4719346A1
EP4719346A1 EP24733306.5A EP24733306A EP4719346A1 EP 4719346 A1 EP4719346 A1 EP 4719346A1 EP 24733306 A EP24733306 A EP 24733306A EP 4719346 A1 EP4719346 A1 EP 4719346A1
Authority
EP
European Patent Office
Prior art keywords
water
pharmaceutically acceptable
hyaluronic acid
soluble hydrolyzed
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24733306.5A
Other languages
German (de)
English (en)
Inventor
Pasqua Oreste
Giorgio Zoppetti
Berardino VAIRA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycores 2000 Srl
Original Assignee
Glycores 2000 Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycores 2000 Srl filed Critical Glycores 2000 Srl
Publication of EP4719346A1 publication Critical patent/EP4719346A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne certaines nouvelles combinaisons de fibroïne hydrolysée soluble dans l'eau et d'acide hyaluronique, ou un sel de celles-ci, éventuellement conjointement avec un agent bioadhésif, des compositions à administrer par voie orale comprenant de telles combinaisons, et leur utilisation en thérapie, en particulier dans la prévention et/ou le traitement de l'oesophagite et, de manière générale, des dommages de l'oesophage épithélial.
EP24733306.5A 2023-05-26 2024-05-24 Nouvelles combinaisons de principes actifs, compositions les contenant et leur utilisation en thérapie Pending EP4719346A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT202300010749 2023-05-26
PCT/IB2024/055080 WO2024246701A1 (fr) 2023-05-26 2024-05-24 Nouvelles combinaisons de principes actifs, compositions les contenant et leur utilisation en thérapie

Publications (1)

Publication Number Publication Date
EP4719346A1 true EP4719346A1 (fr) 2026-04-08

Family

ID=87889616

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24733306.5A Pending EP4719346A1 (fr) 2023-05-26 2024-05-24 Nouvelles combinaisons de principes actifs, compositions les contenant et leur utilisation en thérapie

Country Status (3)

Country Link
EP (1) EP4719346A1 (fr)
CN (1) CN121604957A (fr)
WO (1) WO2024246701A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6924273B2 (en) 2000-10-03 2005-08-02 Scott W. Pierce Chondroprotective/restorative compositions and methods of use thereof
EA018333B1 (ru) * 2008-05-13 2013-07-30 Афарм С.Р.Л. Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов
CN106727099A (zh) * 2016-11-25 2017-05-31 江苏爱西施科技服务咨询股份有限公司 一种去油保湿洁面乳及其制备方法
WO2020205774A1 (fr) * 2019-03-29 2020-10-08 Trustees Of Tufts College Compositions à base de fibroïnes de soie, ses procédés de préparation et ses méthodes d'utilisation
CN112546289A (zh) * 2020-12-11 2021-03-26 北京中卫医正科技有限公司 一种复合生物水凝胶敷料及其制备方法

Also Published As

Publication number Publication date
WO2024246701A1 (fr) 2024-12-05
CN121604957A (zh) 2026-03-03

Similar Documents

Publication Publication Date Title
EP2296670B1 (fr) Utilisation orale de glycosaminoglycanes et compositions correspondantes
EP0245855B1 (fr) Préparations à base de sucralfate destinées à l'application sur la muqueuse de l'oesophage
RU2445977C2 (ru) Водорастворимые пленки, содержащие маловязкие альгинаты
JP2022525509A (ja) 消化管粘膜用保護接着剤
US9241953B2 (en) Glycosaminoglycan oral use and compositions
US12558379B2 (en) Compositions and methods relating to pooled fetal support tissue
Tsibouklis et al. Toward mucoadhesive hydrogel formulations for the management of xerostomia: the physicochemical, biological, and pharmacological considerations
JPH06107550A (ja) 経口抗炎症剤
DK3184115T3 (en) Oral compositions for the treatment of gastroesophageal reflux disease
JPS61205213A (ja) 製剤組成物
WO2010136872A2 (fr) Utilisation d'une combinaison immuable de glycosaminoglycanes et composition à croquer contenant ladite combinaison immuable
Burgalassi et al. Larch arabinogalactan for dry eye protection and treatment of corneal lesions: investigations in rabbits
KR20080039234A (ko) 히아루론산-소수성 폴리 아미노산 공중합체
EP4719346A1 (fr) Nouvelles combinaisons de principes actifs, compositions les contenant et leur utilisation en thérapie
EP3145548B1 (fr) Composition de gel aqueux et son utilisation
WO2023280908A1 (fr) Forme galenique a base de pulpe de baobab, procedes de preparation et utilisations
EP3222270A1 (fr) Compositions pour une adhérence aux muqueuses et leurs utilisations
JP2002522376A (ja) 清澄キサンタンガムを含有する圧縮組成物
WO2023018661A1 (fr) Formulations liquides comprenant de l'acide alginique, de la pectine et du carraghénane et leurs procédés d'utilisation
US6815419B1 (en) Antiulcer agent
HK1257005A1 (en) Water-soluble films comprising low-viscosity alginates
HK1123506B (en) Water-soluble films comprising low-viscosity alginates
HK1123506A (en) Water-soluble films comprising low-viscosity alginates

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251217

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR